Home Cart Sign in  
Chemical Structure| 80573-04-2 Chemical Structure| 80573-04-2

Structure of Balsalazide
CAS No.: 80573-04-2

Chemical Structure| 80573-04-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.

Synonyms: Colazal; Giazo

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Balsalazide

CAS No. :80573-04-2
Formula : C17H15N3O6
M.W : 357.32
SMILES Code : O=C(O)C1=CC(/N=N/C2=CC=C(C(NCCC(O)=O)=O)C=C2)=CC=C1O
Synonyms :
Colazal; Giazo
MDL No. :MFCD00868204

Safety of Balsalazide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Balsalazide

JAK-STAT
pyroptosis

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00269438 Ulcerative Colitis Phase 3 Completed - -
NCT00486031 Inflammatory Bowel Disease ... More >> Ulcerative Colitis Less << Phase 3 Completed - -
NCT00486031 - Completed - -
NCT00408174 Inflammatory Bowel Disease ... More >> Ulcerative Colitis Less << Phase 3 Completed - -
NCT00618202 Ulcerative Colitis COMPLETED 2025-06-05 Novum Pharmaceutical Research ... More >>Services, Houston, Texas, 77042, United States Less <<
NCT00618228 Ulcerative Colitis COMPLETED 2025-01-04 Novum Pharmaceuticals Research... More >> Services, Houston, Texas, 77042, United States Less <<
NCT00649480 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute Ltd. - Cetero Research Fargo, North Dakota, United States, 58104 Less <<
NCT00648531 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.80mL

0.56mL

0.28mL

13.99mL

2.80mL

1.40mL

27.99mL

5.60mL

2.80mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories